Polymer Capital Management’s CorMedix CRMD Stock Holding History

Polymer Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85K	Buy	+12,518	New	+$92.5K	0.01%	777

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Polymer Capital Management's CRMD Position: Q1 2026 in Review

Polymer Capital Management opened a new position in CorMedix (CRMD) in Q1 2026: 12,518 shares worth $85K. The stake represents 0.01% of the portfolio and ranks #777 among its holdings.

187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Polymer Capital Management held 12,518 shares of CorMedix worth $85K as of Q1 2026.
CorMedix was a new Polymer Capital Management position in Q1 2026.
CorMedix made up 0.01% of Polymer Capital Management's portfolio in Q1 2026, its #777 holding.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.